Factor VII Concentrate

Thromb Haemost 1977; 37(03): 572-574
DOI: 10.1055/s-0038-1649270

Letter to the Editor

Schattauer GmbH

Authors

G. W. R Dike

¹Plasma Fractionation Laboratory, Churchill Hospital, Oxford, OX3 7LJ England
D Griffiths

¹Plasma Fractionation Laboratory, Churchill Hospital, Oxford, OX3 7LJ England
A. J Tadman

¹Plasma Fractionation Laboratory, Churchill Hospital, Oxford, OX3 7LJ England

References
1 Bidwell E, Dike G. W. R. 1966. Therapeutic materials in Treatment of Haemophilia and other Coagulation Disorders . In Biggs R, Macfarlane R. G. (Eds.) Oxford: Blackwell Scientific Publications; 43
2 Bidwell E, Rizza C. R, Dike G. W. R, Snape T. J. Clinical use of factor IX concentrates. Thrombosis and Haemostasis 1976; 35: 488
3 Dike G. W. R, Bidwell E, Rizza C. R. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate of factor VII. British Journal of Haematology. 1972; 22: 469
4 Heystek J, Brummelhuis H. G. J, Krijnen H. W. Contributions to the optimal use of human blood II. The large-scale preparation of prothrombin complex. A comparison between two methods using the anion exchangers DEAE-Cellulose DE 52 and DEAE-Sephadex A-50. Vox Sanguinis 1973; 25: 113